Clinical Trial: Phase 1 Crossover Study Evaluating the Safety, Tolerability, and Pharmacokinetics of KP001 in Healthy Adult Volunteers
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Acute Allergic Reaction
Study Type: INTERVENTIONAL
Official Title: A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Crossover Study Evaluating the Safety, Tolerability and Pharmacokinetics of Various Doses of KP001 (Epinephrine Inhalation Aerosol) in Healthy
Brief Summary:
The goal of this clinical trial is to evaluate the safety, tolerability, and pharmacokinetics (PK) of several KP001 dose regimens to identify a treatment regimen with a PK profile that safely meets or exceeds the PK profile of existing injected epinephrine products.The main questions it aims to answer are:To evaluate any carryover effect with a 7-day washout of different dose regimens of KP001 in healthy adult volunteers.To evaluate the safety, tolerability and PK of different dose regimens of KP001 in healthy…
Read more